Autophagy as mechanism for cell death in degenerative aortic valve disease: An underestimated phenomenon in cardiovascular diseases

Autophagy

Volumn 2, Issue 3, 2006, Pages 221-223

  Mistiaen, Wilhelm P ^a,b   Somers, Pamela ^c   Knaapen, Michiel W M ^d   Kockx, Mark M ^d  

^a Hogeschool Antwerpen   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Aortic valve disease; Autophagy; Cell death; Timing of operation; Ubiquitin

Indexed keywords

AORTA VALVE DISEASE; ATHEROSCLEROSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL DEATH; DISEASE COURSE; DRUG DESIGN; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VALVE REPLACEMENT; HUMAN; REVIEW;

EID: 33745866941     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.2671     Document Type: Review

References (29)

1. Stromhaug PE, Klionsky DJ. Approaching the molecular mechanism of autophagy. Traffic 2000; 2:524-31.
2. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 4:463-77.
3. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717-21.
4. Yoshimori T. Autophagy: A regulated bulk degradation process inside cells. Biochem Biophys Res Comm 2004; 313:453-8.
5. Wang CW, Klionsky DJ. The molecular mechanism of autophagy. Molecular Medicine 2003; 9:65-76.
6. Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005; 68:355-65.
7. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Orto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92:216-8.
8. Codogno P, Meijer AJ. Autophagy and signaling: Their role in cell survival and cell death. Cell Death Diff 2005; 12:1509-18.
9. Broker LE, Kruyt FAE, Giaccone G. Cell death independent of caspases: A review. Clin Cancer Res 2005; 11:3155-62.
10. Somers P, Van Cauwelaert P, Muylaert P, Knaapen M, Kockx M, Bonier H, Mistiaen W. Histological evaluation of autophagic cell death in calcified aortic valve stenosis. J Heart Valve Dis 2006; 15:43-48.
11. Martinet W, De Meyer GRY, Andries L, Herman AG, Kockx MM. Detection of autophagy in tissue by standard immunohistochemistry. Possibilities and limitations. Autophagy 2006; 2:55-57.
12. Leggett M, Otto CM. Aortic valve disease. Curr Opin Cardiol 1996; 11:120-5.
13. Otto CM. Aortic stenosis. Clinical evaluation and optimal timing of surgery. Cardiol Clin 1998; 16:353-73.
14. Hilton TC. Aortic valve replacement for patients with mild to moderate aortic stenosis undergoing coronary artery bypass surgery. Clin Cardiol 2000; 23:141-7.
15. Aikawa K, Otto CM. Timing of surgery in aortic stenosis. Prog Cardiovasc Dis 2001; 43:477-93.
16. Mistiaen W, Van Cauwelaert PH, Muylaert PH, Wuyts FL, Harrisson F, Bortier H. Risk factors and survival after aortic valve replacement in octogenarians. J Heart Valve Dis 2004; 13:538-44.
17. Mistiaen W, Van Cauwelaert P, Sys SU, Muylaert P, Harrisson F, Bonier H. Tuning of aortic valve replacement in elderly patients with symptomatic aonic valve disease using outpatient clinical parameters. Acta Clin Belg 2005; 60:185-9.
18. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Kara ES, Applebaum RM, Kronzon I. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002; 162:2345-7.
19. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, Kraft CD, Miyake-Hull CY, Schwaegler RG. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:2262-70.
20. Lester SJ, McElhinney DB, Miller JP, Lutz JT, Otto CM, Redberg RF. Rate of change in aortic valve area during a cardiac cycle can predict the rate of hemodynamic progression of aortic stenosis. Circulation 2000; 101:1947-52.
21. Filsoufi F, Aldog L, Adams DH, Byrne JG. Management of mild to moderate aortic stenosis at the time of coronary artery bypass grafting. J Heart Valve Dis 2002; 11:S45-9.
22. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997; 17:547-52.
23. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in non-rheumatic stenotic aortic valves. Atheroscler Thromb Vasc Biol 1999; 19:1218-22.
24. Martinet W, De Bie M, Schrijvers DM, De Meyer GRY, Herman AG, Kockx MM. 7-Ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24:2296-301.
25. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demet LL. TGFβ1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994; 93:2106-13.
26. Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002; 105:2660-5.
27. Knaapen MWM, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 2001; 51:304-12.
28. Hein S, Elsasser A, Kostin S, Zimmermann R, Schaper J. Functional disturbances due to structural remodeling in the failing human heart. Arch Malad Coeur Vaiss 2002; 95:815-20.
29. Mistiaen W, Van Cauwelaert Ph, Muylaert Ph, Wuyts F, Bortier H. Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial prosthesis in the elderly. J Heart Valve Dis 2005; 14:774-9.